Wealth Enhancement Advisory Services LLC Raises Stock Holdings in DaVita Inc. (NYSE:DVA)

Wealth Enhancement Advisory Services LLC boosted its stake in DaVita Inc. (NYSE:DVA) by 8.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,482 shares of the company’s stock after purchasing an additional 269 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in DaVita were worth $571,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Blue Trust Inc. increased its holdings in shares of DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. purchased a new stake in DaVita during the second quarter valued at about $43,000. Versant Capital Management Inc lifted its stake in DaVita by 90.6% during the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after purchasing an additional 155 shares during the last quarter. Friedenthal Financial purchased a new position in shares of DaVita in the 2nd quarter worth about $48,000. Finally, Point72 Hong Kong Ltd bought a new position in shares of DaVita during the 2nd quarter valued at about $68,000. 90.12% of the stock is currently owned by institutional investors.

DaVita Trading Up 2.2 %

Shares of DVA opened at $150.37 on Friday. The firm has a fifty day simple moving average of $157.17 and a two-hundred day simple moving average of $146.59. DaVita Inc. has a twelve month low of $82.18 and a twelve month high of $168.50. The stock has a market capitalization of $12.33 billion, a P/E ratio of 16.22, a PEG ratio of 0.82 and a beta of 0.89. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the prior year, the company posted $2.85 earnings per share. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, research analysts anticipate that DaVita Inc. will post 9.73 EPS for the current year.

Insider Transactions at DaVita

In related news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the transaction, the insider now owns 83,011 shares in the company, valued at $12,137,038.31. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other DaVita news, CFO Joel Ackerman sold 64,029 shares of DaVita stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the sale, the chief financial officer now directly owns 111,481 shares of the company’s stock, valued at approximately $17,286,243.86. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now owns 83,011 shares in the company, valued at $12,137,038.31. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 173,482 shares of company stock worth $27,387,069. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on DVA shares. Barclays upped their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial increased their target price on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. UBS Group boosted their price target on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Bank of America upped their price target on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research report on Wednesday, August 7th. Finally, TD Cowen lifted their price objective on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.